News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC
Metastatic pancreatic cancer/onco-hema.healthbooktimes.org
Jan 29, 2025, 22:05

Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC

Bertrand Delsuc, CEO and Founder at Biotellytics, shared on X:

“Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib (RMC-9805), an Oral, RAS(ON) G12D-Selective, Tri-Complex Inhibitor in Patients with KRAS G12D PDAC from a Phase 1 in Advanced Solid Tumors.”

Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC

Additional information.

Bertrand Delsuc cancer OncoDaily Oncology
Special Coverage
Blog
Jan 29, 2025, 22:05
Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC
Blog
Jan 29, 2025, 22:05
Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
Blog
Jan 29, 2025, 22:05
Zainab Shinkafi-Bagudu: The HPV vaccine does NOT cause infertility in girls or women
Blog
Jan 29, 2025, 06:59
Yüksel Ürün: The impact of comorbidities on survival in cancer patients receiving ICIs
Blog
Jan 29, 2025, 22:05
Shernan Holtan: Launching ''Transplant and Cell Therapy University'' at Roswell Park Comprehensive Cancer Center
Blog
Jan 29, 2025, 22:05
Katsuaki Maehara: Immunotherapy trials in resectable NSCLC
Blog
Jan 29, 2025, 22:05
Paolo Tarantino: Terrific 2 weeks for breast oncology
Blog
Jan 29, 2025, 22:05
Vivek Subbiah: AACR elections are here!
Blog
Jan 29, 2025, 22:05
Sandy Duarte: Cancer Ramblings is now officially released into the world
Blog
Jan 29, 2025, 22:05
Cancer care must go beyond the disease to truly make a difference
Blog
Jan 29, 2025, 21:39
Jeff Yang: Assessing Lung Cancer Screening Eligibility of patients in the Boston Lung Cancer Study
Science
Jan 29, 2025, 21:39
Endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer